[three_fourth]
[h2]Course Overview[/h2]
This course provides a comprehensive overview of the importance of project management across the various drug development stages and organizational areas within a pharmaceutical company. The course lays a solid foundation for professionals transitioning into a project management role, while also offering new tools and strategies to seasoned managers looking to improve their efficiency, effectiveness and communication across their programs and projects.
Through interactive presentations, discussions, and workshops, course participants learn how to manage different types of programs and projects typical in a global pharmaceutical environment. From the hard skills in project management—planning, scheduling, scope management, risk & issue management, resource planning, and budget oversight–to the softer skills of team leadership, relationship management, effective communication, and negotiation and influence, this valuable course covers everything a project manager needs in order to be successful in today’s pharmaceutical organizations.
[h3]Benefits of Attendance[/h3]
[icon_list type=”triangle”]
- Learn how project management can directly benefit the product lifecycle and operations in the pharmaceutical industry
- Develop practical, hands-on skills you can apply immediately in your own job and workplace
- Interact with other pharmaceutical industry professionals to gain greater insight into current best practices and issue resolution
- Be better prepared for audits, regulatory requirements and FDA communication
[/icon_list]
[h3]Download the final course agenda for PERI’s education program designed for pharmaceutical project managers.[/h3]
[space height=”5″]
[tabs]
[tab title=”Educational Objectives”]
[icon_list type=”triangle”]
- Describe the full product lifecycle in the pharmaceutical industry, and how the varied roles in project/program management drive performance and mitigates risk to the organization
- Demonstrate how project management principles and techniques are applied to the lifecycle and organizational operations to streamline optimal delivery
- Construct and manage more effective, high-performing project teams
- Evaluate risks and issues well in advance, and to effectively mitigate and/or resolve them promptly
[/icon_list]
[/tab]
[tab title=”Key Topics”]
[icon_list type=”triangle”]
- The Pharmaceutical Development Process and Environment
- The Art and Science of Project Management
- Hard and Soft Project Management Skills
- Organizational Challenges and Opportunities
- Project Risk & Issue Resolution
- Effective Team Communications
[/icon_list]
[/tab]
[tab title=”Who Should Attend”]
[icon_list type=”triangle”]
- Program and Project Managers
- Project Team Members
- Managers and Directors in the Pharmaceutical industry
- R & D, IT and other Pharmaceutical Professionals
- Pharmaceutical Pharmacists
[/icon_list]
[/tab]
[tab title=”Continuing Education”]
Continuing Education Credit
Pharmaceutical Education & Research Institute, Inc. (PERI) is pleased to make continuing education credit available for PERI Open Courses. To receive credit, you must attend the entire program and submit the Continuing Education Application form directly to a PERI on-site coordinator. Additional $35 fee applies for students who are applying for continuing education credit.
No continuing education information is available for this program.
[clear]
[clear]
[/tab]
[/tabs]
[clear]
[h3]PERI Faculty Biography[/h3]
David Fritsch, MBA
Project Management Consultant, Fritsch Consulting of MA
Head of F&E, Strategic Programs, PMO and Operational Excellence (OE), Sanofi Genzyme
Adjunct Faculty, Olin Business School, Washington University – St. Louis
As Senior Director at Sanofi Genzyme, David Fritsch is responsible to drive execution and delivery of Allston Site Strategy and the Cerezyme Manufacturing Project Portfolio. Responsibilities included the construction, installation and qualification of new process areas within the Allston Facility, while maintaining Cerezyme production to the market. Previously, David has acted as Senior Director, Engineering at Gallus Biopharmaceuticals (acquired by Patheon) where he was responsible for driving the development and growth of a multi-site, contract manufacturing organization (CMO) for the biopharmaceutical industry.
Additionally, David is an adjunct professor at Washington University in St. Louis, where he teaches Strategic and Crisis Communication in the MBA program at the Olin Business School. David holds a B.S. Chemical Engineering from the University of Notre Dame and an MBA from Washington University in St. Louis. David is a Senior leader with extensive business and operations management experience in biologics, pharmaceuticals and chemicals manufacturing.
[h3]Commercial Support[/h3]
No monetary or in-kind financial support (faculty’s time) has been provided a commercial interest for this program.
[/three_fourth]
[one_fourth_last]
[h3]Event Details[/h3]
Date: May 2020
Location: PERI Training Facility
9302 Lee Highway
Fairfax, VA 22031
This course has been postponed to Fall 2020. Please visit the new course page to register for the next session.
[space height=”5″]
[h3]Recommended Hotel[/h3]
Courtyard by Marriott
Dunn Loring/Fairfax
2722 Gallows Road
Vienna, VA 22180
703-573-9555
[space height=”5″]
[h3]Request a Proposal[/h3]
Interested in bringing this course to your group of 10 or more? Request a proposal and a PERI team member will be in touch about hosting this course as a Corporate Education program.
[button_medium color=”orange” url=”/corporate-education/request-a-proposal/”] Request Proposal[/button_medium]
[space height=”20″]
[h4]Course Information[/h4]
Lauren Kirk
Course Manager
571-490-8409
[button_small color=”slate” url=”mailto:lkirk@peri.org”]Email Question[/button_small]
[space height=”20″]
[h4]Our Students[/h4]
[sliders]
[slider]
[dropcap1]1[/dropcap1] “This provided an overview of the drug development process which enables me to understand the tasks my colleagues undertake.”
[/slider]
[slider]
[dropcap2]2[/dropcap2] “Love the workshops! Excellent activities and follow-up discussions. I learned that it is not easy to manage a portfolio because of all the elements you must consider.”
[/slider]
[/sliders]
[/one_fourth_last]
[space height=”1″]